Helen of Troy Limited reported unaudited consolidated earnings results for the third quarter and nine months ended November 30, 2018. For the quarter, the company reported sales revenue, net of USD 431,081,000 compared to USD 420,841,000 a year ago. Operating income was USD 61,296,000 compared to USD 67,340,000 a year ago. Income from continuing operations was USD 54,320,000 compared to USD 58,624,000 a year ago. Net income was USD 49,470,000 compared to net loss of USD 30,436,000 a year ago. Total earnings per share – diluted were USD 1.88 against total loss per share – diluted of USD 1.12 a year ago. Total earnings per share – diluted from continuing operations were USD 2.06 against USD 2.15 a year ago.

For the nine months, the company reported sales revenue, net of USD 1,179,308,000 compared to USD 1,091,281,000 a year ago. Operating income was USD 155,283,000 compared to USD 137,630,000 a year ago. Income from continuing operations was USD 136,510,000 compared to USD 120,504,000 a year ago. Net income was USD 131,279,000 compared to net loss of USD 15,635,000 a year ago. Total earnings per share – diluted were USD 4.95 against total loss per share – diluted of USD 0.57 a year ago. Total earnings per share – diluted from continuing operations were USD 5.15 against USD 4.41 a year ago.

For the fourth quarter of fiscal year 2019, the company expects diluted EPS from continuing operations to be in the range of USD 1.20 to USD 1.36.

For the fiscal year 2019, the company is updating its outlook for consolidated net sales revenue to be in the range of USD 1.535 to USD 1.550 billion, which implies consolidated sales growth of 3.8% to 4.8% after accounting for the expected impact from the adoption of ASU 2014-09 ‘Revenue from Contracts with Customers' in fiscal 2019 with conforming reclassifications to fiscal 2018. The company's sales outlook now includes the following items, which together account for the USD 10 million reduction to the high end of the range and primarily impact the Health & Home segment: An expected unfavorable impact from pricing actions that have not been resolved with a key customer in two of its product categories; and a deceleration of growth in China ecommerce, with corresponding high inventory levels in the channel for one of its product categories. Finally, the company's net sales outlook now reflects the following expectations by segment: Housewares net sales growth of 11% to 13% compared to the prior expectation of 9% to 11%; Health & Home net sales growth of 2% to 4%, including an unfavorable impact of approximately 2.3% from the average cough/cold/flu season assumption, compared to the prior expectation of 5% to 7%; and Beauty net sales decline in the low- to mid-single digits, which remains the same. The company expects diluted EPS from continuing operations to be in the range of USD 6.35 to USD 6.51.